Overview of Aclarion's Latest Innovations
Aclarion, Inc. (NASDAQ: ACON), a healthcare technology company dedicated to addressing chronic low back pain, showcased its innovative Nociscan solution at a recent global neuroscience conference. This event emphasized the importance of cutting-edge technologies in understanding and diagnosing discogenic pain.
Panel Discussion Highlights
The panel discussion, held at the International Society of Pain and Neuroscience (ISPN), focused on the use of MR Spectroscopy as a critical tool in identifying biomarkers that indicate the presence of discogenic pain. Session co-moderator Doug Beall, M.D., highlighted the significance of disc chemistry in accurately diagnosing chronic pain conditions.
Importance of MR Spectroscopy
MR Spectroscopy has emerged as a revolutionary diagnostic tool, enabling medical professionals to differentiate between painful and non-painful lumbar discs. Aclarion's Nociscan utilizes proprietary algorithms that interpret MR spectroscopy data to reveal actionable insights for better treatment decisions.
Company's Commitment to Pain Management
Brent Ness, CEO of Aclarion, expressed pride in the company's inclusion in such prestigious discussions. He underscored the company's vision and the innovative efforts of the team in advancing diagnostic technologies. The company aims to establish Nociscan as the gold standard for diagnosing chronic low back pain.
The Reach of Chronic Pain
Studies indicate that over 266 million people globally suffer from chronic low back pain, which significantly impacts their quality of life. Aclarion’s commitment to helping physicians identify the source of this pain has positioned it as a leader in this essential healthcare sector.
Integration of Multidisciplinary Approaches
John Sutcliffe, co-moderator of the session, appreciated the inclusive discussions that brought together orthopedic and neurosurgeons. His experience at the London Spine Clinic illustrates a 30-year dedication to employing multidisciplinary approaches to enhance patient care.
Looking Ahead with Aclarion
Aclarion continues to look forward with optimism regarding the future of MR Spectroscopy in chronic pain diagnosis. Their advance through Nociscan not only serves medical professionals but ultimately aims to provide relief to countless patients suffering from debilitating pain.
Contact Information
To learn more about Nociscan and its capabilities, interested parties can reach out via email at info@aclarion.com.
Frequently Asked Questions
What is Nociscan?
Nociscan is Aclarion’s innovative platform using MR Spectroscopy to identify biomarkers related to discogenic pain.
How does MR Spectroscopy work in this context?
MR Spectroscopy analyzes chemical characteristics of spinal discs to differentiate between painful and non-painful conditions.
What was the focus of the recent panel discussion?
The focus was on the efficacy of MR Spectroscopy in diagnosing discogenic pain at the ISPN conference.
How can I access Nociscan services?
Potential patients can inquire about Nociscan centers via Aclarion's website or contact them directly.
What is Aclarion’s mission?
Aclarion aims to provide innovative solutions that help physicians identify sources of chronic low back pain effectively.
